FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > Ehlers Danlos syndrome and MCAS

<< Previous

Bullboard Posts

Next >>

Post by DavidRosenbergon Dec 28, 2022 5:44pm

123 Views

Post# 35194425

Ehlers Danlos syndrome and MCAS

https://www.cnn.com/2022/12/24/health/hypermobile-ehlers-danlos-syndrome-health-hnk-spc-dst-intl/index.html

CNN: "Millions have the same ‘bendy body’ disease as my daughter. Why isn’t the medical profession paying more attention?"

"What’s more, people with hEDS are prone to other conditions, including POTS and MCAS (mast cell activation syndrome)..."

that was a copy from the article ^

luckily 1 of FSD Pharma's CRO (contract research organizations) has started recruitment process for MCAS

https://stcharlesclinicalresearch.com/mcas-mast-cell-activation-syndrome-24-week-treatment-study/

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions